000 | 02223 a2200649 4500 | ||
---|---|---|---|
005 | 20250517054200.0 | ||
264 | 0 | _c20160812 | |
008 | 201608s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.5322 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWu, Jia-Ru | |
245 | 0 | 0 |
_aHydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression. _h[electronic resource] |
260 |
_bOncotarget _cOct 2015 |
||
300 |
_a32526-44 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
650 | 0 | 4 | _aCell Movement |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEnzyme Activation |
650 | 0 | 4 |
_aFungal Proteins _xpharmacology |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aLIM Domain Proteins _xgenetics |
650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred NOD |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aHu, Chi-Tan | |
700 | 1 | _aYou, Ren-In | |
700 | 1 | _aPan, Siou-Mei | |
700 | 1 | _aCheng, Chuan-Chu | |
700 | 1 | _aLee, Ming-Che | |
700 | 1 | _aWu, Chao-Chuan | |
700 | 1 | _aChang, Yao-Jen | |
700 | 1 | _aLin, Shu-Chuan | |
700 | 1 | _aChen, Chang-Shan | |
700 | 1 | _aLin, Teng-Yi | |
700 | 1 | _aWu, Wen-Sheng | |
773 | 0 |
_tOncotarget _gvol. 6 _gno. 32 _gp. 32526-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.5322 _zAvailable from publisher's website |
999 |
_c25305499 _d25305499 |